Predictable excess hepatotoxicity in the SimpliciTB trial - authors' reply

Muge Cevik^*, Maria Beumont, Eugene Sun, Derek J Sloan, Stephen H Gillespie

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

Original language	English
Article number	e728
Number of pages	1
Journal	Lancet Infectious Diseases
Volume	24
Issue number	12
Early online date	27 Nov 2024
DOIs	https://doi.org/10.1016/S1473-3099(24)00718-7
Publication status	Published - Dec 2024

Access to Document

10.1016/S1473-3099(24)00718-7

1 Article

Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial
Cevik, M., Thompson, L. C., Upton, C., Rolla, V. C., Malahleha, M., Mmbaga, B., Ngubane, N., Abu Bakar, Z., Rassool, M., Variava, E., Dawson, R., Staples, S., Lalloo, U., Louw, C., Conradie, F., Eristavi, M., Samoilova, A., Skornyakov, S. N., Ntinginya, N. E. & Haraka, F. & 28 others, Praygod, G., Mayanja-Kizza, H., Caoili, J., Balanag, V., Dalcolmo, M. P., McHugh, T., Hunt, R., Solanki, P., Bateson, A., Crook, A. M., Fabiane, S., Timm, J., Sun, E., Spigelman, M., Sloan, D. J., Gillespie, S. H., Bruinenberg, P., Beumont, M., Nedelman, J., Li, M., Zuma-Gwala, N., Rajaram, S., Choo, L., Wills, G., Betteridge, M., Leandra, L., Olugbosi, M. & Borisov, S., 1 Sept 2024, In: The Lancet Infectious Diseases. 24, 9, p. 1003-1014 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File

Cite this

@article{b8602c726aec42c989c7df9bc97778fa,

title = "Predictable excess hepatotoxicity in the SimpliciTB trial - authors' reply",

author = "Muge Cevik and Maria Beumont and Eugene Sun and Sloan, {Derek J} and Gillespie, {Stephen H}",

year = "2024",

month = dec,

doi = "10.1016/S1473-3099(24)00718-7",

language = "English",

volume = "24",

journal = "Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier",

number = "12",

}

TY - JOUR

T1 - Predictable excess hepatotoxicity in the SimpliciTB trial - authors' reply

AU - Cevik, Muge

AU - Beumont, Maria

AU - Sun, Eugene

AU - Sloan, Derek J

AU - Gillespie, Stephen H

PY - 2024/12

Y1 - 2024/12

U2 - 10.1016/S1473-3099(24)00718-7

DO - 10.1016/S1473-3099(24)00718-7

M3 - Comment/debate

C2 - 39481422

SN - 1473-3099

VL - 24

JO - Lancet Infectious Diseases

JF - Lancet Infectious Diseases

IS - 12

M1 - e728

ER -